Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Preston, Noel W.
1975.
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques.
p.
347.
Preston, Noel W.
1975.
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques.
p.
341.
Cameron, Jack
1976.
Advances in Applied Microbiology Volume 20.
Vol. 20,
Issue. ,
p.
57.
Parker, Charlotte
1976.
Advances in Applied Microbiology Volume 20.
Vol. 20,
Issue. ,
p.
27.
Preston, Noel W.
1976.
Prevalent serotypes ofBordetella pertussisin non-vaccinated communities.
Journal of Hygiene,
Vol. 77,
Issue. 1,
p.
85.
Bronne–Shanbury, Caroline J.
and
Dolby, Jean M.
1976.
The stability of the serotypes ofBordetella pertussiswith particular reference to serotype 1,2,3,4.
Journal of Hygiene,
Vol. 76,
Issue. 2,
p.
277.
Preston, N. W.
and
Stanbridge, T. N.
1976.
Mouse or man? Which are pertussis vaccines to protect?.
Journal of Hygiene,
Vol. 76,
Issue. 2,
p.
249.
Preston, NoelW.
1976.
PROTECTION BY PERTUSSIS VACCINE.
The Lancet,
Vol. 307,
Issue. 7968,
p.
1065.
Iaria, Sebastião Timo
1977.
Pesquisa de antigenos aglutinantes "major" 1, 2 e 3 em cepas de Bordetella pertussis, isoladas de crianças com coqueluche atendidas no Hospital de Isolamento Emílio Ribas de São Paulo, Brasil.
Revista de Saúde Pública,
Vol. 11,
Issue. 3,
p.
410.
Kumazawa, Norichika H.
and
Yoshikawa, Masanosuke
1978.
Conversion of Bordetella pertussis to Bordetella parapertussis.
Journal of Hygiene,
Vol. 81,
Issue. 1,
p.
15.
Hann, I.M
Palmer, M.K
Morris-Jones, P.H
and
Evans, D.I.K
1981.
CHILDHOOD LEUKAEMIA AND SOCIAL STATUS.
The Lancet,
Vol. 318,
Issue. 8258,
p.
1282.
Pittman, Margaret
and
Wardlaw, Alastair C.
1981.
The Prokaryotes.
p.
1075.
Preston, N.W.
1981.
CAMPYLOBACTER SEROTYPES AND EPIDEMIOLOGY.
The Lancet,
Vol. 318,
Issue. 8258,
p.
1283.
Preston, N. W.
Surapatana, Narekul
and
Carter, E. J.
1982.
A reappraisal of serotype factors 4, 5 and 6 ofBordetella pertussis.
Journal of Hygiene,
Vol. 88,
Issue. 1,
p.
39.
PARKER, CHARLOTTE D.
1986.
Monoclonal Antibodies Against Bacteria.
p.
165.
Brennan, M J
Li, Z M
Cowell, J L
Bisher, M E
Steven, A C
Novotny, P
and
Manclark, C R
1988.
Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis.
Infection and Immunity,
Vol. 56,
Issue. 12,
p.
3189.
Foxall, P.A.
Drasar, B.S.
and
Duggleby, C.J.
1990.
Evidence for a DNA inversion system inBordetella pertussis.
FEMS Microbiology Letters,
Vol. 69,
Issue. 1-2,
p.
1.
MacGregor, D.
Coote, J.G.
Duggleby, C.J.
and
Parton, R.
1991.
Serotype variation inBordetella pertussisis governed bycis-acting elements.
FEMS Microbiology Letters,
Vol. 78,
Issue. 2-3,
p.
333.
de Moissac, Y R
Ronald, S L
and
Peppler, M S
1994.
Use of pulsed-field gel electrophoresis for epidemiological study of Bordetella pertussis in a whooping cough outbreak.
Journal of Clinical Microbiology,
Vol. 32,
Issue. 2,
p.
398.
Williamson, Peter
and
Matthews, Ruth
1996.
Epitope mapping the Fim2 and Fim3 proteins ofBordetella pertussiswith sera from patients infected with or vaccinated against whooping cough.
FEMS Immunology & Medical Microbiology,
Vol. 13,
Issue. 2,
p.
169.